Migdal Insurance & Financial Holdings’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.9M | Hold |
|
|||||
|
2025
Q4 | $18.1M | Hold |
|
|||||
|
2025
Q3 | $15.4M | Hold |
|
|||||
|
2025
Q2 | $10.6M | Sell |
|
|||||
|
2025
Q1 | $8.7M | Buy |
|
|||||
|
2024
Q4 | $7.31M | Hold |
|
|||||
|
2024
Q3 | $8.72M | Hold |
|
|||||
|
2024
Q2 | $11.5M | Hold |
|
|||||
|
2024
Q1 | $10.3M | Buy |
|
|||||
|
2023
Q4 | $9.72M | Hold |
|
|||||
|
2023
Q3 | $9.08M | Sell |
|
|||||
|
2023
Q2 | $7.23M | Hold |
|
|||||
|
2023
Q1 | $6.45M | Hold |
|
|||||
|
2022
Q4 | $6.19M | Hold |
|
|||||
|
2022
Q3 | $5.81M | Hold |
|
|||||
|
2022
Q2 | $5.72M | Hold |
|
|||||
|
2022
Q1 | $6.08M | Hold |
|
|||||
|
2021
Q4 | $6.64M | Hold |
|
|||||
|
2021
Q3 | $11.7M | Hold |
|
|||||
|
2021
Q2 | $10.7M | Hold |
|
|||||
|
2021
Q1 | $13.6M | Sell |
|
|||||
|
2020
Q4 | $13.3M | Hold |
|
|||||
|
2020
Q3 | $14.2M | Hold |
|
|||||
|
2020
Q2 | $19.3M | Hold |
|
|||||
|
2020
Q1 | $13.2M | Hold |
|
|||||
|
2019
Q4 | $24.6M | Sell |
|
|||||
|
2019
Q3 | $18.4M | Buy |
|
|||||
|
2019
Q2 | $12.7M | Hold |
|
|||||
|
2019
Q1 | $13.1M | Buy |
|